OpenAlex
PricingAboutJobs
Log inGet started
Work

Real-World LAG3 Expression as A Biomarker in Advanced Melanoma: Implications for Treatment Selection.

PubMed

Year: 2026
Type: article
Study design: Observational Study
Source: PubMed
DOI: 10.1093/oncolo/oyag441
Authors: Inderjit Mehmi, Jonathan E Cohen, Kathryn Bollin, Siwen Hu-Lieskovan, Adam Dugan, Binyam Yilma, Stamatina Fragkogianni, Unnati Jariwala, Jacob Mercer, Omid Hamid
Institutions: Angeles Clinic and Research Institute, Hebrew University of Jerusalem, Hadassah Medical Center, Huntsman Cancer Institute, Tempus Labs (United States)
Language: English

Topic: Cancer Immunotherapy and Biomarkers
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: LAG-3, advanced melanoma, immune checkpoint molecules, PD-L1, CD8+ T cell infiltration, tumor immune microenvironment, objective response rate, overall survival, tumor mutational burden, neoantigen burden
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W7225867350
FWCI:
Cites:
Cited by:
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms